Alan Fuhrman

Overview

Alan Fuhrman received $4M in total compensation, including $458K in salary, at Tyra Biosciences in 2023. Alan Fuhrman also received an average of $419K at OncoGenex Pharmaceuticals from 2006 to 2008.

Source: SEC filings on April 18, 2024, April 19, 2010, and April 13, 2009.

Related executives

We found 16 more executives who work or worked at Tyra Biosciences and OncoGenex Pharmaceuticals.

Todd Harris

Tyra Biosciences

Chief Executive Officer

Hiroomi Tada

Tyra Biosciences

Chief Medical Officer

Ali Fawaz

Tyra Biosciences

General Counsel

Daniel Bensen

Tyra Biosciences

Chief Operating Officer

John Bencich

OncoGenex Pharmaceuticals

Chief Executive Officer

Richard Stewart

OncoGenex Pharmaceuticals

Chairman

Cindy Jacobs

OncoGenex Pharmaceuticals

Chief Medical Officer

Ronald Swanson

Tyra Biosciences

Chief Scientific Officer

News

You may also like